Omar Abdel-Rahman (O Abdel-Rahman)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 99

Top Venues

Journal of comparative effectiveness research

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Expert review of gastroenterology & hepatology

International journal of colorectal disease

University of Alberta

Ain Shams University Faculty of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alberta Jul 01 2019

Canada

Assistant Professor :: Oncology

University of Calgary Mar 01 2018 - Jun 01 2019

Canada

Fellow :: Oncology

Ain Shams University Faculty of Medicine Sep 24 2014 - Mar 01 2018

Egypt

Lecturer :: Clinical Oncology

Ain Shams University Faculty of Medicine Mar 01 2007 - Sep 24 2014

Egypt

Assistant lecturer :: Clinical Oncology

Education History

Ain Shams University Faculty of Medicine Jul 01 2010

Egypt

PHD :: Clinical Oncology

Ain Shams University Faculty of Medicine Jul 01 2007 - Nov 10 2009

Egypt

MSC :: Clinical Oncology

Publications

Aria Jazdarehee, Omar Abdel-Rahman, Jennifer E Jacquier
Remission of Ectopic Cushing Syndrome Secondary to Medullary Thyroid Cancer With Vandetanib and Selpercatinib. JCEM case reports 2 (2) (2024)
Aria Jazdarehee, Omar Abdel-Rahman, Jennifer E Jacquier
Remission of Ectopic Cushing Syndrome Secondary to Medullary Thyroid Cancer With Vandetanib and Selpercatinib. JCEM case reports 2 (2) (2024)
Xiaoyang Lan, Gabrielle Robin, Jessica Kasnik, Grace Wong, Omar Abdel-Rahman
Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma. Cancers 15 (4) (2023)
Omar Abdel-Rahman, Sunita Ghosh
Changes in the outcomes of patients with anaplastic thyroid carcinoma over the past two decades. Endocrine (2023)
Xiaoyang Lan, Gabrielle Robin, Jessica Kasnik, Grace Wong, Omar Abdel-Rahman
Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma. Cancers 15 (4) (2023)
Hyejee Ohm, Omar Abdel-Rahman
Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 30 (1) (2023)
Xiaoyang Lan, Gabrielle Robin, Jessica Kasnik, Grace Wong, Omar Abdel-Rahman
Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma. Cancers 15 (4) (2023)
Hyejee Ohm, Omar Abdel-Rahman
Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 30 (1) (2023)
Hyejee Ohm, Omar Abdel-Rahman
Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 30 (1) (2023)
Hyejee Ohm, Omar Abdel-Rahman
Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 30 (1) (2023)
Hyejee Ohm, Omar Abdel-Rahman
Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 30 (1) (2023)
Firas Baidoun, Zahi Merjaneh, Rama Nanah, Anas M Saad, Omar Abdel-Rahman
Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver. Journal of comparative effectiveness research 11 (13) (2022)
Ali Fawaz, Omar Abdel-Rahman
Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management. Cancer management and research 14 (2022)
Matthew Anaka, Omar Abdel-Rahman
Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment. Cancer management and research 14 (2022)
Xiaoyang Lan, Nicola Fazio, Omar Abdel-Rahman
Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms. Metabolites 12 (11) (2022)
Omar Abdel-Rahman, Sunita Ghosh, Nicola Fazio
Sex-based differences in the outcomes of patients with lung carcinoids. Journal of comparative effectiveness research 11 (7) (2022)
Omar Abdel-Rahman, Sunita Ghosh
Pregnancy and perinatal outcomes following exposure to antineoplastic agents around pregnancy within the US FDA Adverse Event Reporting System. Future oncology (London, England) 18 (21) (2022)
Omar Abdel-Rahman
A real-world, population-based study for the outcomes of patients with metastatic colorectal cancer to the liver with distant lymph node metastases treated with metastasectomy. Journal of comparative effectiveness research 11 (4) (2022)
Omar Abdel-Rahman, Patricia A Tang, Sunita Ghosh, Andrew Scarfe
Patterns of emergency department visits preceding colorectal cancer diagnosis: a population-based study. Journal of comparative effectiveness research 11 (5) (2022)
Hala Mahdi, Layth Mula-Hussain, Zhian S Ramzi, Marwan Tolba, Omar Abdel-Rahman, Ibrahim Abu-Gheida, Ola Khorshid, Sana A Al Sukhun, Nadeem P Siddiqi, Zahid Al Mandhari, Maysa Al Hussaini
Cancer Burden Among Arab-World Females in 2020: Working Toward Improving Outcomes. JCO global oncology 8 (2022)
Omar Abdel-Rahman, S Ghosh, D Morrish
Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms. Journal of endocrinological investigation 45 (9) (2022)
Ali Fawaz, Omar Abdel-Rahman
Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management. Cancer management and research 14 (2022)
Omar Abdel-Rahman
Patterns of cigarette smoking and alcohol drinking among Canadian adults with cancer in a contemporary national cohort. Journal of cancer survivorship : research and practice (2021)
Omar Abdel-Rahman, Scott North
Socioeconomic disparities in the prevalence of comorbid chronic conditions among Canadian adults with cancer. Acta oncologica (Stockholm, Sweden) (2021)
Omar Abdel-Rahman
Impact of postoperative radiotherapy on the outcomes of resected adrenocortical carcinoma-a real-world, population-based study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2021)
Omar Abdel-Rahman, Nicola Fazio
Outcomes of small-cell versus large-cell gastroenteropancreatic neuroendocrine carcinomas: A population-based study. Journal of neuroendocrinology 33 (5) (2021)
Omar Abdel-Rahman
Association between PD-L1 inhibitor, tumor site and adverse events of potential immune etiology within the US FDA adverse event reporting system. Immunotherapy 13 (17) (2021)
Omar Abdel-Rahman, Cynthia Wu, Jacob Easaw
Risk of arterial and venous thromboembolic events among patients with colorectal carcinoma: a real-world, population-based study. Future oncology (London, England) 17 (30) (2021)
Omar Abdel-Rahman, Hatim Karachiwala, Sheryl Koski
Patterns of colorectal cancer diagnosis among younger adults in a real-world, population-based cohort. Future oncology (London, England) 18 (1) (2021)
Omar Abdel-Rahman
Revisiting the AJCC staging system of adrenocortical carcinoma. Journal of endocrinological investigation (2021)
Firas Baidoun, Anas M Saad, Omar Abdel-Rahman
Prognostic and predictive value of microsatellite instability status among patients with colorectal cancer. Journal of comparative effectiveness research 10 (16) (2021)
Omar Abdel-Rahman
Patterns and association of vaccination among adults with a history of cancer in the USA: a population-based study. Journal of comparative effectiveness research 10 (11) (2021)
Omar Abdel-Rahman, Patricia A Tang, Sheryl Koski
Hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy: a real-world study. International journal of colorectal disease 36 (9) (2021)
Omar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski
Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma. Medical oncology (Northwood, London, England) 38 (2) (2021)
Omar Abdel-Rahman
Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study. Journal of comparative effectiveness research 10 (2) (2021)
Omar Abdel-Rahman
Outcomes of patients with nonmetastatic gastric adenocarcinoma according to perioperative treatment strategy: a real-world, population-based study. Journal of comparative effectiveness research 10 (15) (2021)
Omar Abdel-Rahman
Factors associated with fatal coronavirus disease 2019 infections among cancer patients in the US FDA Adverse Event Reporting System database. Future oncology (London, England) 17 (36) (2021)
Omar Abdel-Rahman
Gender, socioeconomic status and emergency department visits among cancer survivors in the USA: a population-based study. Journal of comparative effectiveness research 10 (12) (2021)
Omar Abdel-Rahman
Assessment of the AJCC staging system of pheochromocytomas/paragangliomas. Endocrine (2021)
Omar Abdel-Rahman
Prognostic value of HPV status among patients with hypopharyngeal carcinoma: a population-based study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (9) (2020)
Omar Abdel-Rahman, Sheryl Koski, Karen Mulder
Real-world patterns of chemotherapy administration and attrition among patients with metastatic colorectal cancer. International journal of colorectal disease 36 (3) (2020)
Omar Abdel-Rahman, Nuh Rahbari, Christoph Reissfelder, Hani Oweira
Outcomes of non-metastatic poorly differentiated gastroenteropancreatic neuroendocrine neoplasms treated with surgery: a real-world population-based study. International journal of colorectal disease 36 (5) (2020)
Haidar El Darsa, Rola El Sayed, Omar Abdel-Rahman
MET Inhibitors for the Treatment of Gastric Cancer: What's Their Potential? Journal of experimental pharmacology 12 (2020)
Omar Abdel-Rahman, S Ghosh, J Walker
Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (9) (2020)
Omar Abdel-Rahman
Experiences of cancer patients with outpatient care in the USA: a population-based study. Journal of comparative effectiveness research 9 (13) (2020)
Omar Abdel-Rahman
Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis. International journal of clinical oncology 25 (5) (2020)
Omar Abdel-Rahman
Prediagnostic BMI and thyroid cancer incidence in the PLCO trial. Future oncology (London, England) 15 (30) (2020)
Omar Abdel-Rahman
A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery. International journal of colorectal disease 35 (4) (2020)
Omar Abdel-Rahman
Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study. International journal of clinical oncology 25 (5) (2020)
Omar Abdel-Rahman
Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study. Journal of comparative effectiveness research 9 (6) (2020)
Omar Abdel-Rahman
Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer. Journal of comparative effectiveness research 9 (17) (2020)
Omar Abdel-Rahman, P A Tang, W Y Cheung
Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (10) (2020)
Omar Abdel-Rahman
Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. International journal of clinical oncology 24 (12) (2019)
Omar Abdel-Rahman
Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients? Journal of comparative effectiveness research 8 (8) (2019)
Omar Abdel-Rahman, Hatim Karachiwala
Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials. International journal of colorectal disease 34 (10) (2019)
Omar Abdel-Rahman
ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials. International journal of colorectal disease 34 (12) (2019)
Omar Abdel-Rahman
Outcomes of metastatic breast cancer patients in relationship to disease-free interval following primary treatment of localized disease; a pooled analysis of two clinical trials. The breast journal 25 (5) (2019)
Omar Abdel-Rahman
Outcomes of clinically localized prostate cancer patients managed with initial monitoring approach versus upfront local treatment: a North American population-based study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (12) (2019)
Omar Abdel-Rahman
Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinoma. Future oncology (London, England) 15 (19) (2019)
Omar Abdel-Rahman, Osama Ahmed
Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer. International journal of colorectal disease 34 (4) (2019)
Gwang Hun Jeong, Keum Hwa Lee, I Re Lee, Ji Hyun Oh, Dong Wook Kim, Jae Won Shin, Andreas Kronbichler, Michael Eisenhut, Hans J van der Vliet, Omar Abdel-Rahman, Brendon Stubbs, Marco Solmi, Nicola Veronese, Elena Dragioti, Ai Koyanagi, Joaquim Raduà, Youn Ho Shin
Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis. Journal of clinical medicine 8 (2) (2019)
Omar Abdel-Rahman
Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (4) (2018)
Omar Abdel-Rahman
Impact of baseline characteristics on extensive-stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study. The clinical respiratory journal 12 (10) (2018)
Anas M Saad, Tarek Turk, Muneer J Al-Husseini, Omar Abdel-Rahman
Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC cancer 18 (1) (2018)
Anwar Giryes, Hani Oweira, Meinrad Mannhart, Omar Abdel-Rahman
Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials. Expert review of gastroenterology & hepatology 12 (8) (2018)
Omar Abdel-Rahman
Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging. Breast cancer research and treatment 172 (1) (2018)
Omar Abdel-Rahman, Yuan Xu, Patricia A Tang, Richard M Lee-Ying, Winson Y Cheung
A real-world, population-based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer. Cancer medicine 7 (12) (2018)
Omar Abdel-Rahman, Hani Oweira, Anwar Giryes
Health-related quality of life in cancer patients treated with PD-(L)1 inhibitors: a systematic review. Expert review of anticancer therapy 18 (12) (2018)
Omar Abdel-Rahman
Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : An individual patient data analysis of three clinical trials. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 195 (4) (2018)
Omar Abdel-Rahman
Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (6) (2018)
Omar Abdel-Rahman
Predictors of skeletal-related events among cancer patients with bone metastases treated with zoledronic acid: a secondary analysis of a randomized study. Expert opinion on drug safety 17 (8) (2018)
Omar Abdel-Rahman
Global trends in mortality from malignant mesothelioma: Analysis of WHO mortality database (1994-2013). The clinical respiratory journal 12 (6) (2018)
Omar Abdel-Rahman
Patterns of on-treatment cardiac adverse events within three clinical trials of adjuvant anthracycline-based chemotherapy. Breast cancer (Tokyo, Japan) 25 (6) (2018)
Omar Abdel-Rahman, Winson Y Cheung
External validation of the prostascore model in patients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study. BJU international 122 (3) (2018)
Omar Abdel-Rahman
Outcomes of early-stage breast cancer patients treated with sequential anthracyclines-taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (2) (2018)
Omar Abdel-Rahman
Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study. Journal of cancer research and clinical oncology 144 (5) (2018)
Hani Oweira, Anwar Giryes, Meinrad Mannhart, Michael Decker, Omar Abdel-Rahman
Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials. Expert review of gastroenterology & hepatology 12 (10) (2018)
Anas M Saad, Muneer J Al-Husseini, Ahmed Elgebaly, Omar A Aboshady, Sami Salahia, Omar Abdel-Rahman
Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study. Expert review of gastroenterology & hepatology 12 (4) (2018)
Omar Abdel-Rahman
Risk of cardiac death among cancer survivors in the United States: a SEER database analysis. Expert review of anticancer therapy 17 (9) (2017)
Omar Abdel-Rahman
An analysis of clinical characteristics and patient outcomes in primary mediastinal sarcomas. Expert review of anticancer therapy 17 (11) (2017)
Omar Abdel-Rahman
Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis. Breast cancer research and treatment 164 (1) (2017)
Mostafa Eltobgy, Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Michael Decker, Omar Abdel-Rahman
Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert review of neurotherapeutics 17 (7) (2017)
Omar Abdel-Rahman
Smoking and EGFR status may predict outcomes of advanced NSCLC treated with PD-(L)1 inhibitors beyond first line: A meta-analysis. The clinical respiratory journal 12 (5) (2017)
Omar Abdel-Rahman
Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients. Expert review of anticancer therapy 18 (2) (2017)
Hani Oweira, Jan Schmidt, Daniel Helbling, Ulf Petrausch, Othmar Schöb, Arianeb Mehrabi, Anwar Giryes, Hazem Elhadedy, Omar Abdel-Rahman
Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients. Expert review of gastroenterology & hepatology 11 (9) (2017)
Shaimaa Lasheen, Kyrillus S Shohdy, Loay Kassem, Omar Abdel-Rahman
Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis. Expert review of anticancer therapy 17 (9) (2017)
Omar Abdel-Rahman
Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV? PloS one 12 (11) (2017)
Emma B Holliday, Pamela K Allen, Hesham Elhalawani, Omar Abdel-Rahman
Treatment at a high-volume centre is associated with improved survival among patients with non-metastatic hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 38 (4) (2017)
Yousery Nada, Noha Rashad, Mai Eissa, Aya Ghonaim, Kyrillus Farag, Islam Saadawi, Ahmed Sheha, Mahmoud El Gewaity, Omar Abdel-Rahman
Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort study. Expert review of gastroenterology & hepatology 12 (1) (2017)
Omar Abdel-Rahman
Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis. The clinical respiratory journal 12 (3) (2017)
Omar Abdel-Rahman
Impact of tumor size on the outcome of patients with small renal cell carcinoma. Expert review of anticancer therapy 17 (8) (2017)
Omar Abdel-Rahman
Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (6) (2017)
Omar Abdel-Rahman
Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting. Breast cancer research and treatment 168 (1) (2017)
Omar Abdel-Rahman
Validation of the 8th AJCC staging system for gastric cancer in a population-based setting. Expert review of gastroenterology & hepatology 12 (5) (2017)
Omar Abdel-Rahman
Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (4) (2017)
Omar Abdel-Rahman
Incorporating age into International Germ Cell Consensus Classification (IGCCC): a time to move forward? Expert review of anticancer therapy 18 (1) (2017)
Omar Abdel-Rahman
Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (5) (2017)
Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Omar Abdel-Rahman
Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis. Expert review of gastroenterology & hepatology 11 (7) (2017)
Omar Abdel-Rahman
Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 19 (11) (2017)

Omar Abdel-Rahman.css-eqlu8i{font-size:small;padding-left:4px;} (O Abdel-Rahman)

Publication Activity (10 Years)

Top Topics

Top Venues

Omar Abdel-Rahman (O Abdel-Rahman)